Shared-link access · Not indexed

Retatrutide Dosing Calculator

A step-by-step calculator for reconstitution volumes, syringe draw, and protocol reference. Educational use only — all dosing decisions require a licensed medical provider.

Read full Retatrutide profile →

Peptide

Vial Setup

Regimen

Card

Retatrutide

Also known as: LY3437943

Clinical / FDA-approved — Protocol evidence level

Investigational triple GIP/GLP-1/glucagon agonist. NOT FDA approved and not available as a prescription drug — only as research material. Clinical regimen reflects published Phase 2 trial titration; community use of gray-market material is unproven and carries unknown purity/dosing risk.

Last reviewed: 2026-06-12

Contraindications — Do not use if:

•Personal/family history of medullary thyroid carcinoma or MEN2 (GLP-1 class boxed-warning concern)
•Pregnancy / breastfeeding — no safety data
•History of pancreatitis
•Severe gastrointestinal disease / gastroparesis